Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-02-22 @ 12:23 PM
Study NCT ID:
NCT03926169
Status:
COMPLETED
Last Update Posted:
2022-08-11
First Post:
2019-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-23
First Submit QC Date:
None
Study First Post Date:
2019-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-07-14
Results First Submit QC Date:
None
Results First Post Date:
2022-08-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-01-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-07-14
Last Update Post Date:
2022-08-11
Last Update Post Date Type:
ACTUAL